Press release Oncology Venture – First day of trading in TO2 warrants

NEXT STORY
Atlantic Healthcare Hosts Key Opinion Leader Discussion on Unmet Medical Need in Ulcerative Colitis and the Advantages of Alicaforsen
PREV STORY
Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Maryland’s Largest Independent GI Provider Announces Grand Re-Opening Near Bowie

author_avatar
NASDAQ Market News

Strongbridge Biopharma plc Reports Third Quarter 2019 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Novartis provides update on Phase III study evaluating canakinumab (ACZ885) as second or third-line treatment in combination with chemotherapy in non-small cell lung cancer

author_avatar
NASDAQ Market News